Hepatitis B virus (HBV) immunization is safe and has been accepted worldwide as a routine
practice. The target of such vaccination is to induce the immune response in the host …

Hepatitis B Virus (HBV) is a significant public health challenge. Around 250 million people
live with chronic HBV infection. With a global approach to this issue, we focus on new …

Context: Despite various studies, there is no overall estimation about the efficacy of Hepatitis
B virus (HBV) vaccine among healthcare workers (including healthcare personnel and …

Introduction: Vaccination is an important tool in hepatitis B prevention. However, several
vaccine doses are required to induce long-term protection. Several at-risk groups have …

Background. In human immunodeficiency virus (HIV)− infected patients, the immunogenicity
of hepatitis B vaccines is impaired. The primary and secondary aims of our study were to …

Anti-CD20 have quickly become the mainstay in the treatment of multiple sclerosis (MS) and
other neuroinflammatory conditions. However, when they are used as a maintenance …

Worldwide, the AIDS pandemic continues almost relentlessly. Women are now representing
the fastest growing group of newly infected HIV-1 infected patients. The risk of mother-to …

A randomized study of injecting drug users in a Danish prison comparing vaccination at 0, 1
and 3 weeks with the 0, 1 and 6 months schedule (20μg Engerix B im) was conducted. Due …

Hepatitis B virus remains a major health burden but it is preventable by education and
vaccination. Greater resources are required to expand vaccination to the at-risk, sexually …

Introduction Despite an effective vaccine, hepatitis B virus (HBV) infection continues to
impose a large burden of disease globally. Until childhood immunisation achieves high …